Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P030053/S085

MENTOR MemoryGel Breast Implants

Mentor Corp. · Decision date Jul 21, 2026

FDA DECISIONP030053/S085

What did the FDA approve?

FDA records P030053/S085 as a supplement to PMA P030053, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Jul 21, 2026.

FDA approval order statement

For introduction of an Overall Compliance Rate in addition to the existing FDA-defined target rate and Introduction of a Call Center to assist patient troubleshooting concerns
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
General, Plastic Surgery
Decision date
Jul 21, 2026
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P030053/S085
Regulatory pathway
PMA supplement
Applicant
Mentor Corp.
Product code
FTR
Decision code
APPR
Decision date
Jul 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Applicant
Mentor Corp.
Product code
FTR
FDA device class
3

For the original device and its historical approval scope, see PMA P030053. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P030053 · Original PMA

    MEMORYGEL SILICONE GEL -FILLED BREAST IMPLANTS

  2. P030053/S072 · Related supplement

    Mentor MemoryGel Breast Implants

  3. P030053/S082 · Related supplement

    MENTOR MemoryGel Silicone Gel-Filled Breast Implants

  4. P030053/S080 · Related supplement

    MemoryGel Silicone Gel-Filled Breast Implants

  5. P030053/S085 received

    Application receipt date recorded by FDA.

  6. P030053/S084 · Related supplement

    MENTOR MemoryGel Silicone Gel-Filled Breast Implants

  7. P030053/S086 · Related supplement

    MENTOR MemoryGel Silicone Gel-Filled Breast Implants

  8. P030053/S087 · Related supplement

    MENTOR MemoryGel Breast Implants

  9. P030053/S088 · Related supplement

    MemoryGel Silicone Gel-Filled Breast Implant

  10. P030053/S089 · Related supplement

    MENTOR MemoryGel Silicone Gel-Filled Breast Implants

  11. P030053/S083 · Related supplement

    MENTOR MemoryGel Enhance Breast Implants

  12. P030053/S085 · FDA decision

    Normal 180 Day Track No User Fee

  13. P030053/S093 · Related supplement

    MemoryGel Breast Implants

Timeline entries are records held by MedtechLedger for P030053. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P030053

Product / regulatory recordCompanyPathwayDecision dateSource
Mentor Corp.PMA approvalNov 17, 2006FDA
Mentor Corp.PMA supplementAug 6, 2025FDA
Mentor Corp.PMA supplementAug 8, 2025FDA
Mentor Corp.PMA supplementAug 12, 2025FDA
Mentor Corp.PMA supplementDec 17, 2025FDA
Mentor Corp.PMA supplementJan 2, 2026FDA
Mentor Corp.PMA supplementFeb 4, 2026FDA
Mentor Corp.PMA supplementApr 30, 2026FDA
Mentor Corp.PMA supplementMay 1, 2026FDA
Mentor Corp.PMA supplementMay 11, 2026FDA
Mentor Corp.PMA supplementOct 23, 2026FDA

Explore the linked device profile

Other records with product code FTR

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mentor Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
33 Technology Dr., Irvin, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records